Oxipit ChestLink

by Oxipit (part of Sectra group)  · Based in Lithuania → — The world's first autonomous radiology AI
Emergency Medicine Pulmonology Radiology

Overview

Oxipit ChestLink is an AI-powered medical imaging tool designed for autonomous reporting of normal chest X-ray studies. It is intended for use by radiologists and healthcare providers in various care settings, including primary care and outpatient clinics, to manage high volumes of chest X-rays.

  • What it does: ChestLink analyzes chest X-ray images to identify studies with no abnormalities. When the AI is highly confident that a study is normal, it autonomously generates a final patient report without requiring radiologist intervention. If the AI cannot confidently rule out abnormalities, the study is routed for radiologist review.
  • Who it is for: This tool is primarily for radiologists and radiology departments seeking to optimize workflow and reduce the reporting burden of routine, normal chest X-rays.
  • How it fits a clinical workflow: ChestLink integrates into existing PACS and RIS environments. It can operate in a supervised mode, where preliminary reports are monitored, or in an autonomous prospective reporting mode for high-confidence normal cases. Deployment typically begins with a retrospective analysis of a facility’s chest X-ray data to estimate the proportion of studies that can be autonomously reported.
  • Notable capabilities: ChestLink is capable of identifying normal chest X-ray studies with high sensitivity. It aims to automate a portion of the daily chest X-ray workload, allowing radiologists to focus on more complex cases. The software is certified as a CE Class IIb medical device.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Autonomous healthy patient report generation
  • 99.9% sensitivity in detecting normal chest X-rays
  • Automates up to 40% of radiologists' workflow for healthy chest X-rays
  • Abnormality detection and highlighting in chest X-rays
  • Triage functionality for prioritizing X-rays
  • Integration in standard reading environment (PACS) and RIS (Radiological Information System)
  • Real-time reporting data and periodic reporting summaries via analytics dashboard
  • Reduces radiologist workload
  • Enhances diagnostic accuracy
  • Supports confident decision-making

Use Cases

  • Automating healthy chest X-ray reporting
  • Reducing radiologist workload for routine cases
  • Improving efficiency in radiology workflows
  • Prioritizing complex cases for radiologists
  • Real-time quality assurance for chest X-ray reports
  • Prophylactic (occupational) health checks

What Physicians Need to Know

Evidence Base
ChestLink is the first fully autonomous AI medical imaging product with a CE mark (Class IIb medical device certification). It was trained on a dataset of over 500,000 images. The algorithms support 75 different pathologies.
Clinical Validation Studies
ChestLink has undergone multiple clinical validation studies. A study analyzing 10,000 chest X-rays from Finnish primary care patients found that ChestLink identified normal studies with 99.8% sensitivity and 36.4% specificity, with a minimal number of false negatives and no critical findings missed. Another study published in Radiology in March 2023 highlighted the tool's high sensitivity for various chest diseases, stating no major mistakes were found in their database. A UK study on 140,000 scans showed a discordance rate of only 4%, dropping to 1% after consultant radiologist review, indicating ChestLink missed only 1% of cases that should have been deemed abnormal. In a retrospective and prospective validation involving approximately 20,000 chest radiographs, ChestLink demonstrated the capacity to autonomously report 15u201320% of studies as normal with 99.9% sensitivity.
Alert Fatigue Management
ChestLink is designed to reduce radiologist workload by autonomously reporting on chest X-rays with no abnormalities, allowing radiologists to focus on cases with pathologies. It can automate up to 30-40% of daily X-ray workflow. In cases where ChestLink cannot confidently rule out actionable radiological findings, the study is directed to a radiologist for review, effectively managing alerts by only escalating potentially abnormal cases.
Override Rate Data
In a UK study of 140,000 scans, the initial discordance rate between ChestLink and radiologists was 4%, which dropped to 1% after a consultant radiologist's review. This suggests a low override rate for ChestLink's 'normal' classifications.
Differential Diagnosis Support
While ChestLink's primary function is autonomous reporting of *normal* chest X-rays, its companion product, ChestEye, detects 75 common findings in chest X-rays, localizes them, and produces preliminary reports. This suggests that the broader Oxipit CXR Suite offers comprehensive diagnostic support, with ChestLink handling the 'no abnormality' cases and ChestEye assisting with the identification of specific pathologies.
Clinical Workflow Integration
ChestLink integrates with standard reading environments (PACS) and Radiological Information Systems (RIS). It can be deployed as a cloud-based, hybrid, or on-premise solution. The analysis is triggered automatically after image acquisition, with processing times ranging from 10-60 seconds. Deployment typically follows a three-stage framework: retrospective analysis, supervised operations, and then autonomous reporting. The system provides an analytics dashboard with real-time updates and daily summaries for transparency and traceability of application decisions.
Decision Audit Trail
ChestLink provides an analytics dashboard with real-time reporting data and periodic reporting summaries for full transparency and traceability of application actions and decisions.
Physician Tip

ChestLink is particularly valuable for managing high volumes of chest X-rays, especially in primary care settings where a significant percentage of studies are normal. By autonomously reporting on these 'no abnormality' cases, it frees up radiologist time to focus on more complex or urgent studies, potentially reducing workload and improving turnaround times. Physicians should be aware that ChestLink is designed for autonomous reporting of *normal* studies; any suspicious findings are flagged for radiologist review. The system's high sensitivity for detecting abnormalities ensures that critical findings are not missed.

ChestLink integrates with existing Healthcare IT systems, including PACS and RIS, and can be accessed via AI marketplaces or distribution platforms. It supports DICOM SR or HL7 messaging for output. Oxipit has partnerships with platforms like deepcOS and Sectra, facilitating seamless integration into various clinical environments.

Details

Category Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Unknown — unknown
DeploymentCloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

Oxipit plans on certifying ChestLink through the Food and Drug Administration (FDA) for eventual use in the United States. Currently, autonomous operation is CE marked and available in Europe, but not for autonomous use in the United States.

Integrations
EHR Not specified
Specialties Emergency Medicine, Pulmonology, Radiology

What the Web Says

Oxipit ChestLink is an autonomous AI medical imaging application designed to interpret chest X-rays and identify normal studies without radiologist intervention, aiming to reduce workload and improve efficiency in healthcare. It has received CE Class IIb certification in the EU, making it the first fully autonomous AI medical imaging product with such a mark. Studies have shown high sensitivity in identifying normal chest X-rays and a low discordance rate for abnormal cases after consultant review.

Overall: Positive

Strengths

  • Reduces radiologist workload by autonomously reporting normal chest X-rays.
  • High sensitivity (99.8-99.9%) in identifying normal chest X-rays.
  • Minimal missed critical findings in studies.
  • Potential to optimize healthcare resources and improve reporting times.
  • Can autonomously report a significant percentage of normal studies (e.g., 10.5% of all studies, 23.4% of normal scans in one study).
  • Acts as a safety net and can improve diagnostic consistency through quality assurance features.

Limitations

  • Initial clinical enthusiasm among radiologists can be mixed due to a natural inclination to trust their own judgment.
  • Some debate exists regarding the full autonomy of AI in medical imaging and legal ramifications.
  • CE mark is quicker to obtain and requires less investigation than FDA clearance, which might raise questions for some in the US market.
  • Concerns about potential lawsuits related to missed diagnoses by AI have been raised.
  • Some radiologists find existing AI software to be more of a hindrance than a help, particularly if their workflow is already efficient.
  • The AI is only fully autonomous for normal CXR cases; any suspicion of abnormality is still left for a radiologist to decide.

Based on reviews from: AuntMinnieEurope, YouTube (Dr. Adi Kale - University Hospital Birmingham), Reddit (r/artificial, r/medicine, r/radiologyAI), Oxipit Official Website (Case Study, News/Insights), Health AI Register, Hardian Health, Startup Reporter, MarkTechPost, cloud-net.pl, G2, PMC (PubMed Central)

Last updated: 2026-10-04

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Oxipit ChestLink

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Oxipit ChestLink.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
MCG Health
MCG Health
Clinical Decision Support & Reference
MCG Health provides industry-leading evidence-based guidance and technologies to optimize health outcomes, drive operational efficiency, and achieve cost savings. Their solutions are utilized by thousands of hospitals, a majority of U.S. health plans, and various government health programs.
i2i Population Health
Azara Healthcare
Clinical Decision Support & Reference
Azara Healthcare, having acquired i2i Population Health, provides a population health management platform that integrates diverse data sources to enhance care coordination, quality management, and analytics for healthcare providers.
IVA (Intelligent Voice AI)
IVAI
Clinical Decision Support & Reference
IVA (Intelligent Voice AI) by IVAI offers ambient listening and automated medical scribing for healthcare, integrating with EHRs like Epic to enhance documentation, compliance, and operational efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-09-30 | First Added: 2026-09-30
AI Tool Finder
AI-powered search. Results may not be comprehensive.